Clinical Trial Update: Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1, single-dose study evaluating the safety of sarilumab and tocilizumab in rheumatoid arthritis. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab)
• KEVZARA (sarilumab)

Snippet

Sponsor: Sanofi | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED